Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Macular degeneration gains higher UK profile:

This article was originally published in Clinica

Executive Summary

The diagnosis and treatment of age-related macular degeneration (AMD), an area of growing interest, is currently the subject of several research projects funded by the UK Department of Health. Funded through the Medical Research Council, these include studies into the genetic susceptibility to the disease, which has received a £1.5 million ($2.1 million) grant. A clinical trial assessing radiotherapy in the treatment of subfoveal neovascular membranes in AMD is also underway at the Royal Victoria Hospital in Belfast.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071497

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel